Amino acid transporter (xCT) influences the growth and progression of non-small cell lung cancer. So, a team of researchers used an anti-inflammatory drug known as sulfasalazine to reduce the formation of the tumor by inhibiting the function of xCT, reports a new study. The findings of the study are published in the journal iOncogene/i.
xCT is an amino acid transporter, which carries the amino acid cystine into the cells and exports glutamate, a chemical that nerve cells use to send signals to other cells....
↧